Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Arthritis Rheum. 2013 Jun;65(6):1430–1438. doi: 10.1002/art.37916

Figure 2.

Figure 2

Shift in LDL-C category at 24 weeks compared to baseline among Methotrexate + etanercept patients and methotrexate monotherapy patients. A. Methotrexate and etanercept. B. Methotrexate monotherapy. LDL-C = low density lipoprotein cholesterol